SCYNEXIS, Inc. (SCYX)
NASDAQ: SCYX · Real-Time Price · USD
0.7010
+0.0010 (0.14%)
Jul 11, 2025, 9:22 AM - Market open
SCYNEXIS Market Cap
SCYNEXIS has a market cap or net worth of $27.35 million as of July 11, 2025. Its market cap has decreased by -62.89% in one year.
Market Cap
27.35M
Enterprise Value
-10.81M
1-Year Change
-62.89%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since May 2, 2014, SCYNEXIS's market cap has decreased from $76.10M to $27.35M, a decrease of -64.06%. That is a compound annual growth rate of -8.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2025 | 27.10M | -40.96% |
| Dec 31, 2024 | 45.90M | -44.70% |
| Dec 29, 2023 | 83.00M | 63.06% |
| Dec 30, 2022 | 50.90M | -65.16% |
| Dec 31, 2021 | 146.10M | 74.55% |
| Dec 31, 2020 | 83.70M | 57.63% |
| Dec 31, 2019 | 53.10M | 129.87% |
| Dec 31, 2018 | 23.10M | -65.16% |
| Dec 29, 2017 | 66.30M | -13.33% |
| Dec 30, 2016 | 76.50M | -11.46% |
| Dec 31, 2015 | 86.40M | 1.65% |
| Dec 31, 2014 | 85.00M | 11.70% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 706.88B |
| Johnson & Johnson | 375.52B |
| AbbVie | 336.82B |
| Novo Nordisk | 308.58B |
| UnitedHealth Group | 274.02B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.15B |
| AstraZeneca | 218.25B |